Charlestown, MA, United States of America

Matthew Omon Herigstad

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 6.7

ph-index = 10

Forward Citations = 269(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Matthew Omon Herigstad: Innovator in Protein Purification

Introduction

Matthew Omon Herigstad is a prominent inventor based in Charlestown, MA (US). He has made significant contributions to the field of protein production and purification, holding a total of 11 patents. His work focuses on developing methods that enhance the quality and efficacy of protein-based therapies.

Latest Patents

Herigstad's latest patents include innovative techniques for protein purification. One notable patent is for "Protein purification methods to reduce acidic species," which addresses the challenges in controlling charge variants, aggregates, and fragments of proteins during purification processes. Another significant patent is titled "Low acidic species compositions and methods for producing and using the same." This invention relates to low acidic species compositions, particularly involving antibodies, and outlines methods for producing these compositions to treat disorders where TNFα is detrimental.

Career Highlights

Matthew Omon Herigstad has established a successful career at AbbVie Inc., where he continues to advance research in protein purification. His expertise in this area has led to the development of methods that improve the therapeutic potential of protein-based treatments.

Collaborations

Herigstad collaborates with esteemed colleagues, including Natarajan Ramasubramanyan and Lihua Yang. These partnerships enhance the innovative capacity of his research and contribute to the advancement of the field.

Conclusion

Matthew Omon Herigstad is a key figure in the realm of protein purification, with a strong portfolio of patents that reflect his innovative spirit. His contributions are paving the way for improved therapeutic solutions in the biotechnology industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…